Randomized phase II trial of carboplatin-paclitaxel compared to carboplatin-paclitaxel-trastuzumab in advanced or recurrent uterine serous carcinomas that overexpress HER2/Neu (NCT01367002): Updated survival analysis
- Resource Type
- Source
- Gynecologic Oncology. 159:7-8
- Subject
Oncology Obstetrics and Gynecology - Language
- ISSN
- 0090-8258